2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Sarcopenia
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Neoplasms
1
Myelodysplastic Syndromes
1
Muscle Weakness
1
Leukemia, Myeloid
1
Hematologic Neoplasms
1
Heart Failure
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Cardiotoxicity
1
Breast Neoplasms
1
Anemia, Aplastic
1
Interventions
Cyclophosphamide
23
fludarabine phosphate
19
Whole-Body Irradiation
17
fludarabine
16
Melphalan
16
Tacrolimus
14
Busulfan
14
Peripheral Blood Stem Cell Transplantation
11
Mycophenolic Acid
11
Alemtuzumab
9
Cyclosporine
7
Methotrexate
6
Antilymphocyte Serum
6
thymoglobulin
4
Stem Cell Transplantation
4
Thiotepa
3
Methylprednisolone
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
AP 1903 reagent
3
sargramostim
2
Transplantation
2
Sirolimus
2
Rituximab
2
Mesna
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Hematopoietic Stem Cell Transplantation
2
Flow Cytometry
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
nicotinamide-beta-riboside
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled